An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Seagen to Present at the J.P. Morgan Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Seagen Inc. (NASDAQ: SGEN) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 3:00 p.m. PT. The event will be webcast live and available for replay on the company’s investor website. Seagen is a global biotechnology firm focused on discovering, developing, and commercializing innovative cancer treatments. Headquartered in Seattle, Washington, the company has additional locations in California, Canada, Switzerland, and the European Union. For further details on its product offerings and pipeline, visit www.seagen.com.
Positive
None.
Negative
None.
BOTHELL, Wash.--(BUSINESS WIRE)--
Seagen Inc. (Nasdaq:SGEN) today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 3:00 p.m. Pacific Time. The presentation will be webcast live and available for replay from the investor section of Seagen’s website at investor.seagen.com.
About Seagen
Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.
